Oslo, Norway, August 26, 2022 - Radforsk Investeringsstiftelse, a legal person closely associated with a primary insider of Nykode Therapeutics ASA has notified the company of a pledge of shares in Nykode Therapeutics ASA.

Please refer to the attached for further information.


This information made public by Nykode Therapeutics ASA pursuant to article 19 of the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.